Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / U.S. PHARMA ETF
-
Total 13F shares
-
691,897
-
Share change
-
-33,947
-
Total reported value
-
$117,318,733
-
Put/Call ratio
-
46%
-
Price per share
-
$169.54
-
Number of holders
-
108
-
Value change
-
-$7,558,289
-
Number of buys
-
34
-
Number of sells
-
47
Institutional Holders of ISHARES TR - U.S. PHARMA ETF (IHE) as of Q3 2022
As of 30 Sep 2022,
ISHARES TR - U.S. PHARMA ETF (IHE) was held by
108 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
691,897 shares.
The largest 10 holders included
WELLS FARGO & COMPANY/MN, MORGAN STANLEY, BANK OF AMERICA CORP /DE/, ROYAL BANK OF CANADA, RAYMOND JAMES & ASSOCIATES, BROWN ADVISORY INC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, UBS Group AG, LPL Financial LLC, and Fisher Asset Management, LLC.
This page lists
109
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.